• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,502.12 579.48
( 0.75%)
Global Indices
Nasdaq
52,333.78 -6.42
(-0.01%)
Dow Jones
7,505.37 -14.99
(-0.20%)
Hang Seng
68,854.54 -1,620.42
(-2.30%)
Nikkei 225
10,664.80 186.46
(1.78%)
Forex
USD-INR
94.60 0.11
(0.12%)
EUR-INR
107.91 0.13
(0.12%)
GBP-INR
125.27 0.26
(0.21%)
JPY-INR
0.58 0.00
(-0.20%)

EQUITY - MARKET SCREENER

Nephro Care India Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
92991
INE0SUN01013
34.4868498
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
NEPHROCARE
33.63
113.1
EPS(TTM)
Face Value()
Div & Yield %
2.04
10
0
 

Mastek consolidated net profit rises 30.94% in the March 2026 quarter
Apr 17,2026
Net profit of Mastek rose 30.94% to Rs 106.15 crore in the quarter ended March 2026 as against Rs 81.07 crore during the previous quarter ended March 2025. Sales rose 3.60% to Rs 938.00 crore in the quarter ended March 2026 as against Rs 905.42 crore during the previous quarter ended March 2025.

For the full year,net profit rose 7.47% to Rs 404.00 crore in the year ended March 2026 as against Rs 375.93 crore during the previous year ended March 2025. Sales rose 7.05% to Rs 3698.75 crore in the year ended March 2026 as against Rs 3455.23 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales938.00905.42 4 3698.753455.23 7
OPM %16.0715.32 -15.8315.82 -
PBDT167.43132.71 26 623.95526.67 18
PBT148.96114.05 31 551.34451.55 22
NP106.1581.07 31 404.00375.93 7